Oasis Centre for Reproductive Medicine
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oasis Centre for Reproductive Medicine - overview
Established
2009
Location
Hyderabad, -, India
Primary Industry
Healthcare
About
Oasis Centre for Reproductive Medicine specializes in providing a wide range of fertility treatments, including advanced reproductive technologies, to support couples on their journey to parenthood. Established in 2009 and headquartered in Hyderabad, India, Oasis Centre for Reproductive Medicine focuses on fertility healthcare services. The founders, Durga Rao and Kiran Gadela, have a background in reproductive medicine. In August 2022, Kedaara Capital acquired a significant minority stake in the company through a Secondary Buyout for USD 50 mn, raising the total amount raised to USD 50 mn.
This investment aims to help Oasis pursue synergistic acquisitions and expand its leading fertility platform in India and South Asia. Oasis Fertility provides a comprehensive suite of fertility treatments, including In Vitro Fertilization (IVF), Intra Uterine Insemination (IUI), and Intra-Cytoplasmic Sperm Injection (ICSI). The company operates over 30 centers across 19 cities in India, such as Hyderabad, Chennai, and Bengaluru, catering to couples seeking family planning and fertility care. Their services include personalized treatment plans designed to meet the unique needs of each patient.
In the most recent year, 2023, Oasis Fertility reported revenue of USD 20. 43 mn and an EBITDA of USD 2. 52 mn. The revenue is generated primarily through direct-to-consumer transactions for a range of fertility treatments and procedures, which include consultations and various treatment cycles.
The company’s pricing structure accommodates specific treatment plans and offers financial solutions such as 0% interest on EMIs for procedures. Looking ahead, Oasis Centre for Reproductive Medicine plans to leverage the funding from Kedaara Capital to pursue synergistic acquisitions and enhance its position in the fertility market across India and South Asia. The funding will support the development of new products and expansion into additional markets. The company aims to capitalize on strategic opportunities to create a leading fertility platform by optimizing its service offerings and expanding its geographic reach.
Current Investors
Kedaara Capital
Primary Industry
Healthcare
Sub Industries
Hospitals
Website
www.oasisindia.in
Company Stage
Mature
Total Amount Raised
Subscriber access only
Oasis Centre for Reproductive Medicine - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Oasis Centre for Reproductive Medicine | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.